The corresponding genes of these three DMPs were mesothelin (MSLN), protein kinase cAMP-dependent type II regulatory subunit beta (PRKAR2B), and msh homeobox 1 (MSX1), all of which correlated with tumor development, malignancy, and treatment (Yue et al., 2018b; Hilliard, 2018; Sha et al., 2018). The gene discussed is MSX1; the disease is neoplasm.